ALSO NOTED: Merck vaccine prevents cervical cancer in older women; Diabetes sales drive 37 percent increase in Takeda profits;

> Gardasil protects against cervical cancer in women as old as 45, a new study shows; previously, the vaccine was only proven to work in women ages 9 to 26. Report

> Strong sales of its Actos diabetes drug boosted Takeda Pharmaceuticals to a 37 percent hike in half-year profits. Report

> Cardinal Health posted an 11 percent increase in profits to $301.8 million, but trouble in its pharmaceutical supply-chain services unit prompted a change in management. Report

> Prague's Zentiva Pharmaceuticals saw profits fall 31 percent in the first nine months, but it expects full-year sales to come in with 20 percent growth. Report

> The FDA warned consumers against two unapproved products sold as ED treatments; they contain potentially harmful ingredients that can cause low blood pressure, the agency said. Report

And Finally... Besides its obvious effects, the ED remedy sildenafil citrate may also be a love potion. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.